Natalie Jane Michael
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalie Jane Michael has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Caron
Faculty of Pharmacy Université Laval Quebec City Quebec Canada
8 shared publications - David Spanswick
Neurosolutions Ltd, Coventry, UK
5 shared publications - Olivier Lavoie
Faculty of Pharmacy Université Laval Quebec City Quebec Canada
5 shared publications - Kevin W. Williams
Center for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA; Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
4 shared publications Moein Minbashi Moeini
Faculty of Pharmacy Université Laval Quebec City Quebec Canada
4 shared publications- Garron T. Dodd
Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Australia
3 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (34)
Chronic psychosocial stress: A primary driver of sleep apnea onset in rats and humans
Poor sleep quality and chronic psychosocial stress are interrelated risk factors for hypertension, metabolic disease, and neuropsychiatric disorders. Sleep apnea (SA) is a respiratory disorder that disrupts sleep, affecting ~1 billion adults worldwide. However, the origins of SA remain incompletely understood. Clinically, activation of the stress pathways is often considered a consequence of SA rather than a causal factor. Here, we combined preclinical experiments with Mendelian randomization (MR) analysis to show that chronic psychosocial stress is a primary driver of SA onset. In adult rats, 3 wk of social isolation (SI; single housing) activated the stress response, augmented apneas during natural sleep, and increased the ventilatory responses to O 2 and CO 2 challenges. In supine anesthetized rats, obstructive apneas with O 2 desaturations were 5 times more frequent in SI males than in controls, with no effect in females. SI-related anomalies in airway motor control contribute to the problem. SI also induced increased blood pressure and augmented fat gain, especially in males. In humans, MR analysis using genome-wide association studies of multiple stress-related neurological disorders from European cohorts (~100,000 to 1,096,458 participants) revealed significant effects of loneliness on the risk of SA, independent of adiposity. Together, these results challenge the conventional view of stress as merely a consequence of SA and instead position it as a possible cause. These results open the door to a paradigm shift, recognizing psychosocial stress as a risk factor paves the way for alternative avenues in basic mechanistic research, as well as in preventive and therapeutic strategies.
- 17 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (34)
Open AccessChronic psychosocial stress: A primary driver of sleep apnea onset in rats and humans
Poor sleep quality and chronic psychosocial stress are interrelated risk factors for hypertension, metabolic disease, and neuropsychiatric disorders. Sleep apnea (SA) is a respiratory disorder that disrupts sleep, affecting ~1 billion adults worldwide. However, the origins of SA remain incompletely understood. Clinically, activation of the stress pathways is often considered a consequence of SA rather than a causal factor. Here, we combined preclinical experiments with Mendelian randomization (MR) analysis to show that chronic psychosocial stress is a primary driver of SA onset. In adult rats, 3 wk of social isolation (SI; single housing) activated the stress response, augmented apneas during natural sleep, and increased the ventilatory responses to O 2 and CO 2 challenges. In supine anesthetized rats, obstructive apneas with O 2 desaturations were 5 times more frequent in SI males than in controls, with no effect in females. SI-related anomalies in airway motor control contribute to the problem. SI also induced increased blood pressure and augmented fat gain, especially in males. In humans, MR analysis using genome-wide association studies of multiple stress-related neurological disorders from European cohorts (~100,000 to 1,096,458 participants) revealed significant effects of loneliness on the risk of SA, independent of adiposity. Together, these results challenge the conventional view of stress as merely a consequence of SA and instead position it as a possible cause. These results open the door to a paradigm shift, recognizing psychosocial stress as a risk factor paves the way for alternative avenues in basic mechanistic research, as well as in preventive and therapeutic strategies.
- Open Access
- 24 March 2026
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (4) , e70169
Noradrenergic inhibition of definitive POMC neurons through direct and indirect mechanisms
Norepinephrine is a key neuromodulator of hypothalamic circuits that regulate energy balance. Previous studies suggested that norepinephrine inhibits proopiomelanocortin (POMC) neurons of the arcuate nucleus via α2a‐adrenoceptors (ADRA2A), but the underlying mechanisms and physiological relevance of this pathway were not assessed. We therefore investigated how ADRA2 activation regulates POMC neuron activity and whether Adra2a expressed in POMC neurons contributes to energy and glucose homeostasis in vivo. We used whole‐cell patch clamp electrophysiology in male and female mice to evaluate the impact of norepinephrine and the ADRA2 agonist UK 14,304 on definitive POMC neurons in the arcuate nucleus. We also generated and validated a novel Adra2a ‐flox mouse line, which was crossed with Pomc ‐CreERT2 mice to produce inducible POMC‐specific Adra2a knockout mice (POMC KOA2A ). These mice were used for both electrophysiological analyses and in vivo assessment of energy and glucose homeostasis. Multiplex RNAscope confirmed that Adra2a was highly expressed in ~50% of POMC neurons, with significantly higher expression in females. Norepinephrine and the selective ADRA2 agonist UK 14,304 robustly inhibited POMC neurons in hypothalamic slices, producing hyperpolarization, reduced firing, and decreased input resistance independent of sex. These effects were mediated in part by activation of multiple potassium conductances, as blockade of K ir and K ATP channels attenuated the response. They were also partly indirect, as blockade of synaptic transmission reduced the proportion of neurons that were inhibited. Deletion of Adra2a in definitive POMC neurons had little effect on body weight, food intake, or adiposity, but modestly impaired glucose tolerance in males. Electrophysiological studies revealed that loss of Adra2a in POMC neurons prevented UK 14,304‐induced inhibition in approximately half of POMC neurons, supporting the involvement of both direct and indirect effects of UK 14,304 on POMC neuron activity. In conclusion, ADRA2A robustly inhibits hypothalamic POMC neurons through both direct and indirect mechanisms. However, Adra2a expression in POMC neurons is largely dispensable for the regulation of energy balance. These findings suggest that noradrenergic inhibition of POMC neuron activity involves additional cellular targets or network‐level pathways beyond POMC neurons themselves.
- 24 March 2026
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (4) , e70169
Open AccessNoradrenergic inhibition of definitive POMC neurons through direct and indirect mechanisms
Norepinephrine is a key neuromodulator of hypothalamic circuits that regulate energy balance. Previous studies suggested that norepinephrine inhibits proopiomelanocortin (POMC) neurons of the arcuate nucleus via α2a‐adrenoceptors (ADRA2A), but the underlying mechanisms and physiological relevance of this pathway were not assessed. We therefore investigated how ADRA2 activation regulates POMC neuron activity and whether Adra2a expressed in POMC neurons contributes to energy and glucose homeostasis in vivo. We used whole‐cell patch clamp electrophysiology in male and female mice to evaluate the impact of norepinephrine and the ADRA2 agonist UK 14,304 on definitive POMC neurons in the arcuate nucleus. We also generated and validated a novel Adra2a ‐flox mouse line, which was crossed with Pomc ‐CreERT2 mice to produce inducible POMC‐specific Adra2a knockout mice (POMC KOA2A ). These mice were used for both electrophysiological analyses and in vivo assessment of energy and glucose homeostasis. Multiplex RNAscope confirmed that Adra2a was highly expressed in ~50% of POMC neurons, with significantly higher expression in females. Norepinephrine and the selective ADRA2 agonist UK 14,304 robustly inhibited POMC neurons in hypothalamic slices, producing hyperpolarization, reduced firing, and decreased input resistance independent of sex. These effects were mediated in part by activation of multiple potassium conductances, as blockade of K ir and K ATP channels attenuated the response. They were also partly indirect, as blockade of synaptic transmission reduced the proportion of neurons that were inhibited. Deletion of Adra2a in definitive POMC neurons had little effect on body weight, food intake, or adiposity, but modestly impaired glucose tolerance in males. Electrophysiological studies revealed that loss of Adra2a in POMC neurons prevented UK 14,304‐induced inhibition in approximately half of POMC neurons, supporting the involvement of both direct and indirect effects of UK 14,304 on POMC neuron activity. In conclusion, ADRA2A robustly inhibits hypothalamic POMC neurons through both direct and indirect mechanisms. However, Adra2a expression in POMC neurons is largely dispensable for the regulation of energy balance. These findings suggest that noradrenergic inhibition of POMC neuron activity involves additional cellular targets or network‐level pathways beyond POMC neurons themselves.
- Open Access
- 6 February 2026
- Published by Society for Neuroscience in eneuro
- Vol. 13 (2)
Galanin Inhibits Histaminergic Neurons via Galanin Receptor 1
Galanin-expressing neurons in the ventrolateral preoptic area (VLPO galanin ) are active during sleep and play an important role in regulating non-rapid eye movement (NREM) sleep. It is generally believed that VLPO galanin neurons promote sleep via inhibitory actions in arousal-promoting regions of the brain. Histaminergic neurons are a population of wake-active neurons that receive strong projections from the sleep-active VLPO galanin neurons. However, the ability of galanin to influence the activity of histaminergic neurons has received limited attention. Here, using whole-cell patch-clamp electrophysiological recordings from genetically identified histaminergic neurons in male mice, we explore the mechanisms by which galanin influences histaminergic neuron electrical excitability. Our results reveal that galanin is a powerful inhibitor of histaminergic neuron activity and demonstrate that the inhibitory effects of galanin are mediated by galanin receptor 1 (GALR1) and the subsequent opening of G-protein-coupled inwardly rectifying (GIRK) and large conductance calcium-activated potassium (BK) channels. Furthermore, we identify that histaminergic neurons highly express Galr1 mRNA and show that the GALR1-mediated hyperpolarization of histaminergic neurons is largely independent of action potential-dependent synaptic transmission or fast excitatory or inhibitory neurotransmitters. Together, these results suggest that direct postsynaptic activation of GALR1 expressed on histaminergic neurons mediates the inhibitory effects of galanin on these neurons. This data also supports the notion that the sleep-promoting effects of VLPO galanin neuron activation may occur via the ability of galanin to inhibit the arousal-promoting histaminergic neurons.
- 6 February 2026
- Published by Society for Neuroscience in eneuro
- Vol. 13 (2)
Open AccessGalanin Inhibits Histaminergic Neurons via Galanin Receptor 1
Galanin-expressing neurons in the ventrolateral preoptic area (VLPO galanin ) are active during sleep and play an important role in regulating non-rapid eye movement (NREM) sleep. It is generally believed that VLPO galanin neurons promote sleep via inhibitory actions in arousal-promoting regions of the brain. Histaminergic neurons are a population of wake-active neurons that receive strong projections from the sleep-active VLPO galanin neurons. However, the ability of galanin to influence the activity of histaminergic neurons has received limited attention. Here, using whole-cell patch-clamp electrophysiological recordings from genetically identified histaminergic neurons in male mice, we explore the mechanisms by which galanin influences histaminergic neuron electrical excitability. Our results reveal that galanin is a powerful inhibitor of histaminergic neuron activity and demonstrate that the inhibitory effects of galanin are mediated by galanin receptor 1 (GALR1) and the subsequent opening of G-protein-coupled inwardly rectifying (GIRK) and large conductance calcium-activated potassium (BK) channels. Furthermore, we identify that histaminergic neurons highly express Galr1 mRNA and show that the GALR1-mediated hyperpolarization of histaminergic neurons is largely independent of action potential-dependent synaptic transmission or fast excitatory or inhibitory neurotransmitters. Together, these results suggest that direct postsynaptic activation of GALR1 expressed on histaminergic neurons mediates the inhibitory effects of galanin on these neurons. This data also supports the notion that the sleep-promoting effects of VLPO galanin neuron activation may occur via the ability of galanin to inhibit the arousal-promoting histaminergic neurons.
- Open Access
Topiramate Enhances GABAergic Tone to Orexigenic Neuropeptide Y/Agouti‐Related Peptide ( NPY / AgRP ) Neurons
Objective: Topiramate is a medication used off‐label, or in combination with phentermine, for the management of obesity. However, its mechanism of action remains elusive. As many obesity medications target the brain, we aimed to determine if topiramate influences the activity of hypothalamic melanocortin neurons known to regulate energy balance. Methods: Transgenic mice expressing a fluorescent protein in either “orexigenic” neuropeptide Y/agouti‐related peptide (NPY/AgRP) or “anorexigenic” pro‐opiomelanocortin (POMC) neurons were used to perform whole‐cell patch clamp electrophysiology experiments in the arcuate nucleus (ARC) of the hypothalamus. Results: Topiramate (1 μM) strongly inhibited NPY/AgRP neuron electrical excitability. Despite topiramate's well‐known actions at GABA A receptors, we demonstrate that the topiramate‐induced inhibition of NPY/AgRP neurons does not involve GABA A receptors. The effects of topiramate on NPY/AgRP neurons were suppressed by inhibitors of synaptic transmission and after blockade of GABA B receptors or potassium channels. In contrast, topiramate had negligible influence on the activity of POMC neurons. Conclusions: This study is the first demonstration that topiramate strongly inhibits the activity of ARC NPY/AgRP neurons and suggests that enhanced GABAergic tone to these neurons mediates this effect. The ability of topiramate to inhibit the orexigenic NPY/AgRP neurons may underlie some of its weight‐lowering properties.
Open AccessTopiramate Enhances GABAergic Tone to Orexigenic Neuropeptide Y/Agouti‐Related Peptide ( NPY / AgRP ) Neurons
Objective: Topiramate is a medication used off‐label, or in combination with phentermine, for the management of obesity. However, its mechanism of action remains elusive. As many obesity medications target the brain, we aimed to determine if topiramate influences the activity of hypothalamic melanocortin neurons known to regulate energy balance. Methods: Transgenic mice expressing a fluorescent protein in either “orexigenic” neuropeptide Y/agouti‐related peptide (NPY/AgRP) or “anorexigenic” pro‐opiomelanocortin (POMC) neurons were used to perform whole‐cell patch clamp electrophysiology experiments in the arcuate nucleus (ARC) of the hypothalamus. Results: Topiramate (1 μM) strongly inhibited NPY/AgRP neuron electrical excitability. Despite topiramate's well‐known actions at GABA A receptors, we demonstrate that the topiramate‐induced inhibition of NPY/AgRP neurons does not involve GABA A receptors. The effects of topiramate on NPY/AgRP neurons were suppressed by inhibitors of synaptic transmission and after blockade of GABA B receptors or potassium channels. In contrast, topiramate had negligible influence on the activity of POMC neurons. Conclusions: This study is the first demonstration that topiramate strongly inhibits the activity of ARC NPY/AgRP neurons and suggests that enhanced GABAergic tone to these neurons mediates this effect. The ability of topiramate to inhibit the orexigenic NPY/AgRP neurons may underlie some of its weight‐lowering properties.
- 22 August 2023
- Published by Elsevier in Neuroscience
- Vol. 530, 95-107
Electrophysiological Comparison of Definitive Pro-opiomelanocortin Neurons in the Arcuate Nucleus and the Retrochiasmatic Area of Male and Female Mice
- 22 August 2023
- Published by Elsevier in Neuroscience
- Vol. 530, 95-107
Electrophysiological Comparison of Definitive Pro-opiomelanocortin Neurons in the Arcuate Nucleus and the Retrochiasmatic Area of Male and Female Mice
- 28 June 2023
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (9) , 2412-2418
Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage?
- 28 June 2023
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (9) , 2412-2418
Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage?
- Open Access
- 27 June 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1202089
Histaminergic regulation of food intake
Histamine is a biogenic amine that acts as a neuromodulator within the brain. In the hypothalamus, histaminergic signaling contributes to the regulation of numerous physiological and homeostatic processes, including the regulation of energy balance. Histaminergic neurons project extensively throughout the hypothalamus and two histamine receptors (H1R, H3R) are strongly expressed in key hypothalamic nuclei known to regulate energy homeostasis, including the paraventricular (PVH), ventromedial (VMH), dorsomedial (DMH), and arcuate (ARC) nuclei. The activation of different histamine receptors is associated with differential effects on neuronal activity, mediated by their different G protein-coupling. Consequently, activation of H1R has opposing effects on food intake to that of H3R: H1R activation suppresses food intake, while H3R activation mediates an orexigenic response. The central histaminergic system has been implicated in atypical antipsychotic-induced weight gain and has been proposed as a potential therapeutic target for the treatment of obesity. It has also been demonstrated to interact with other major regulators of energy homeostasis, including the central melanocortin system and the adipose-derived hormone leptin. However, the exact mechanisms by which the histaminergic system contributes to the modification of these satiety signals remain underexplored. The present review focuses on recent advances in our understanding of the central histaminergic system’s role in regulating feeding and highlights unanswered questions remaining in our knowledge of the functionality of this system.
- 27 June 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1202089
Open AccessHistaminergic regulation of food intake
Histamine is a biogenic amine that acts as a neuromodulator within the brain. In the hypothalamus, histaminergic signaling contributes to the regulation of numerous physiological and homeostatic processes, including the regulation of energy balance. Histaminergic neurons project extensively throughout the hypothalamus and two histamine receptors (H1R, H3R) are strongly expressed in key hypothalamic nuclei known to regulate energy homeostasis, including the paraventricular (PVH), ventromedial (VMH), dorsomedial (DMH), and arcuate (ARC) nuclei. The activation of different histamine receptors is associated with differential effects on neuronal activity, mediated by their different G protein-coupling. Consequently, activation of H1R has opposing effects on food intake to that of H3R: H1R activation suppresses food intake, while H3R activation mediates an orexigenic response. The central histaminergic system has been implicated in atypical antipsychotic-induced weight gain and has been proposed as a potential therapeutic target for the treatment of obesity. It has also been demonstrated to interact with other major regulators of energy homeostasis, including the central melanocortin system and the adipose-derived hormone leptin. However, the exact mechanisms by which the histaminergic system contributes to the modification of these satiety signals remain underexplored. The present review focuses on recent advances in our understanding of the central histaminergic system’s role in regulating feeding and highlights unanswered questions remaining in our knowledge of the functionality of this system.
- 1 June 2023
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 324 (6) , E553-E555
Women in metabolic science
- 1 June 2023
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 324 (6) , E553-E555
Women in metabolic science
- Open Access
- 8 February 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 165 (4) , 467-486
A critical update on the leptin‐melanocortin system
The discovery of leptin in 1994 was an “eureka moment” in the field of neurometabolism that provided new opportunities to better understand the central control of energy balance and glucose metabolism. Rapidly, a prevalent model in the field emerged that pro‐opiomelanocortin (POMC) neurons were key in promoting leptin's anorexigenic effects and that the arcuate nucleus of the hypothalamus (ARC) was a key region for the regulation of energy homeostasis. While this model inspired many important discoveries, a growing body of literature indicates that this model is now outdated. In this review, we re‐evaluate the hypothalamic leptin–melanocortin model in light of recent advances that directly tackle previous assumptions, with a particular focus on the ARC. We discuss how segregated and heterogeneous these neurons are, and examine how the development of modern approaches allowing spatiotemporal, intersectional, and chemogenetic manipulations of melanocortin neurons has allowed a better definition of the complexity of the leptin–melanocortin system. We review the importance of leptin in regulating glucose homeostasis, but not food intake, through direct actions on ARC POMC neurons. We further highlight how non‐POMC, GABAergic neurons mediate leptin's direct effects on energy balance and influence POMC neurons. image
- 8 February 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 165 (4) , 467-486
Open AccessA critical update on the leptin‐melanocortin system
The discovery of leptin in 1994 was an “eureka moment” in the field of neurometabolism that provided new opportunities to better understand the central control of energy balance and glucose metabolism. Rapidly, a prevalent model in the field emerged that pro‐opiomelanocortin (POMC) neurons were key in promoting leptin's anorexigenic effects and that the arcuate nucleus of the hypothalamus (ARC) was a key region for the regulation of energy homeostasis. While this model inspired many important discoveries, a growing body of literature indicates that this model is now outdated. In this review, we re‐evaluate the hypothalamic leptin–melanocortin model in light of recent advances that directly tackle previous assumptions, with a particular focus on the ARC. We discuss how segregated and heterogeneous these neurons are, and examine how the development of modern approaches allowing spatiotemporal, intersectional, and chemogenetic manipulations of melanocortin neurons has allowed a better definition of the complexity of the leptin–melanocortin system. We review the importance of leptin in regulating glucose homeostasis, but not food intake, through direct actions on ARC POMC neurons. We further highlight how non‐POMC, GABAergic neurons mediate leptin's direct effects on energy balance and influence POMC neurons. image